Drawing for Serial No. 88180716

USPTO serial 88180716

Serial No. 88180716

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
CRENNAN, KEVIN GERARD
Law office
TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 88180716?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew R. Streger, Esq.

MATTHEW R. STREGER, ESQ. KEAVNEY & STREGER, LLC103 CARNEGIE CENTER, SUITE 300PRINCETON, NJ 08540UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
041Leadership development training in the field of emergency medical servicesACTIVESep 3, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 22, 2019MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Mar 22, 2019ABN1ABANDONMENT - EXPRESS MAILED—
Mar 21, 2019EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Feb 11, 2019GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 11, 2019GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 11, 2019EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Feb 11, 2019CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Feb 8, 2019DOCKASSIGNED TO EXAMINER—
Nov 20, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance